So how exactly does Goto plan to generate smiles across Fujifilm’s four business segments? In the Healthcare segment, the answer is in part by detecting diseases at an early stage. Launched in early 2021, NURA is a chain of emerging country-based health check-up centres that use Fujifilm’s own AI-powered diagnostic imaging equipment to help increase accuracy and support doctors in catching early signs of cancer and myocardial infarction. “Working with our business partners, we currently operate in seven locations in India, Mongolia and Vietnam. We plan to expand to 100 locations, primarily in emerging countries, by 2030,” Goto says.

As the cause of an estimated 1.3 million deaths every year, TB ranks alongside Aids and malaria as one of the world’s most lethal communicable diseases. That’s why ending TB is another big social issue that Fujifilm is helping to tackle. How? Because its small, lightweight portable X-ray device with real-time AI-powered image analysis is ideally suited to bring tuberculosis screening to the remotest regions. “We’re collaborating with private organisations and public entities to expand tuberculosis screenings by deploying these devices in developing countries,” Goto explains.

Japanese company Fujifilm has evolved and expanded dramatically over the past two decades. President and CEO Teiichi Goto explains the purpose that all its different business segments have in common and his plans for the growing business in the run up to 2030.